Harald Vonkeman
Harald Vonkeman
Onbekend partnerschap
Geverifieerd e-mailadres voor mst.nl
Geciteerd door
Geciteerd door
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
M Dougados, M Soubrier, A Antunez, P Balint, A Balsa, MH Buch, ...
Annals of the rheumatic diseases 73 (1), 62-68, 2014
Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention
HE Vonkeman, MAFJ van de Laar
Seminars in arthritis and rheumatism 39 (4), 294-312, 2010
Non-steroidal anti-inflammatory drugs: an overview of cardiovascular risks
IL Meek, MAFJ Van de Laar, H E Vonkeman
Pharmaceuticals 3 (7), 2146-2162, 2010
Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients
EK Richfield, KA Maguire‐Zeiss, HE Vonkeman, P Voorn
Annals of neurology 38 (6), 852-861, 1995
Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis
CS Crowson, S Rollefstad, E Ikdahl, GD Kitas, PLCM Van Riel, SE Gabriel, ...
Annals of the rheumatic diseases 77 (1), 48-54, 2018
Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis
SMW Koop, M Peter, HE Vonkeman, LMM Steunebrink, ...
Arthritis research & therapy 17 (1), 1-8, 2015
Eradication of Helicobacter pylori Does Not Reduce the Incidence of Gastroduodenal Ulcers in Patients on Long‐term NSAID Treatment: Double‐Blind …
HTJI De Leest, KSS Steen, WF Lems, JWJ Bijlsma, MAFJ Van De Laar, ...
Helicobacter 12 (5), 477-485, 2007
Impact of patient-accessible electronic medical records in rheumatology: use, satisfaction and effects on empowerment among patients
R van Der Vaart, CHC Drossaert, E Taal, KW Drossaers-Bakker, ...
BMC musculoskeletal disorders 15 (1), 1-9, 2014
Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: a placebo-controlled, ex vivo, serial placebo-controlled serial crossover study
IL Meek, HE Vonkeman, J Kasemier, KLL Movig, MAFJ van de Laar
European journal of clinical pharmacology 69 (3), 365-371, 2013
Stopping tumor necrosis factor inhibitor treatment in patients with established rheumatoid arthritis in remission or with stable low disease activity: a pragmatic multicenter …
M Ghiti Moghadam, HE Vonkeman, PM Ten Klooster, J Tekstra, ...
Arthritis & rheumatology 68 (8), 1810-1817, 2016
How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis
L Siemons, PM Ten Klooster, HE Vonkeman, PLCM van Riel, CAW Glas, ...
BMC musculoskeletal disorders 15 (1), 1-7, 2014
Performance of the Dutch SF-36 version 2 as a measure of health-related quality of life in patients with rheumatoid arthritis
PM ten Klooster, HE Vonkeman, E Taal, L Siemons, L Hendriks, ...
Health and quality of life outcomes 11 (1), 1-9, 2013
Direct medical costs of serious gastrointestinal ulcers among users of NSAIDs
HE Vonkeman, RM Klok, MJ Postma, JRBJ Brouwers, MAFJ van de Laar
Drugs & aging 24 (8), 681-690, 2007
Disseminated primary varicella infection during infliximab treatment.
H Vonkeman, C ten Napel, H Rasker, M van de Laar
The Journal of rheumatology 31 (12), 2517-2518, 2004
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial
SHM Manders, W Kievit, E Adang, HL Brus, HJB Moens, A Hartkamp, ...
Arthritis research & therapy 17 (1), 1-12, 2015
Understanding the NSAID related risk of vascular events
HE Vonkeman, JRBJ Brouwers, MAFJ van de Laar
Bmj 332 (7546), 895-898, 2006
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
I Nota, CHC Drossaert, E Taal, HE Vonkeman, MAFJ van de Laar
BMC musculoskeletal disorders 15 (1), 1-10, 2014
Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case …
HE Vonkeman, RW Fernandes, J Van der Palen, EN Van Roon, ...
Arthritis research & therapy 9 (3), 1-8, 2007
Increased cardiovascular risk factors in different rheumatic diseases compared with the general population
IL Meek, HSJ Picavet, HE Vonkeman, WMM Verschuren, ...
Rheumatology 52 (1), 210-216, 2013
Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial
CA Janssen, MAH Oude Voshaar, HE Vonkeman, TLTA Jansen, ...
Rheumatology 58 (8), 1344-1352, 2019
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20